Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR407899 in Microvascular Angina and Persistent Stable Angina
NCT03236311Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Oct 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of SAR407899 in microvascular angina (MVA), stable angina, sponsored by Sanofi. Started Oct 2017; status: terminated.
02
Drugs
SAR407899
03
Conditions
microvascular angina (MVA)stable angina
Beyond the preview
Go deeper on NCT03236311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03236311.